vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
38.16
-1.16 (-2.95%)
At close: Feb 27, 2026, 4:00 PM EST
38.25
+0.09 (0.24%)
After-hours: Feb 27, 2026, 4:10 PM EST
vTv Therapeutics Employees
vTv Therapeutics had 23 employees as of December 31, 2024. The number of employees increased by 7 or 43.75% compared to the previous year.
Employees
23
Change (1Y)
7
Growth (1Y)
43.75%
Revenue / Employee
$739
Profits / Employee
-$1,020,435
Market Cap
473.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Lyell Immunopharma | 300 |
| Rocket Pharmaceuticals | 299 |
| 4D Molecular Therapeutics | 227 |
| Solid Biosciences | 100 |
| Invivyd | 100 |
| Lineage Cell Therapeutics | 77 |
| Larimar Therapeutics | 65 |
VTVT News
- 18 hours ago - VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst - Seeking Alpha
- 15 days ago - vTv Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 26 days ago - vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewsWire
- 2 months ago - vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - GlobeNewsWire
- 4 months ago - vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewsWire
- 5 months ago - vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting - GlobeNewsWire
- 6 months ago - UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire